National Institutes of Health Reform Act of 2006
Pub. L. 109-482
126 sections of the Code credited to this law, found between Public Law 109-173 and Public Law 109-482.
- 21 U.S.C. § 360bbb — Expanded access to unapproved therapies and diagnostics
- 42 U.S.C. § 242q-4 — 242q–4. Definitions
- 42 U.S.C. § 242q-5 — 242q–5. Authorization of appropriations
- 42 U.S.C. § 280e-3 — 280e–3. Study in certain States to determine factors contributing to elevated breast cancer mortality rates
- 42 U.S.C. § 281 — Organization of National Institutes of Health
- 42 U.S.C. § 282 — Director of National Institutes of Health
- 42 U.S.C. § 282a — Authorization of appropriations
- 42 U.S.C. § 282b — Electronic coding of grants and activities
- 42 U.S.C. § 283 — Biennial reports of Director of NIH
- 42 U.S.C. § 283a — Annual reporting to increase interagency collaboration and coordination
- 42 U.S.C. § 283a-1 — 283a–1. Annual reporting to prevent fraud and abuse
- 42 U.S.C. § 283a-2 — 283a–2. Annual reporting regarding training of graduate students for doctoral degrees
- 42 U.S.C. § 283a-3 — 283a–3. Establishment of program regarding DES
- 42 U.S.C. § 283d — Children's Vaccine Initiative
- 42 U.S.C. § 283g — Muscular dystrophy; initiative through Director of National Institutes of Health
- 42 U.S.C. § 283h — Office of Rare Diseases
- 42 U.S.C. § 283i — Rare disease regional centers of excellence
- 42 U.S.C. § 284 — Directors of national research institutes
- 42 U.S.C. § 284e — Research on osteoporosis, Paget's disease, and related bone disorders
- 42 U.S.C. § 284f — Parkinson's disease
- 42 U.S.C. § 284g — Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism spectrum disorder
- 42 U.S.C. § 284h — Pediatric Research Initiative
- 42 U.S.C. § 284i — Autoimmune diseases
- 42 U.S.C. § 284j — Muscular dystrophy research
- 42 U.S.C. § 284l — Enhancement awards
- 42 U.S.C. § 284m — Program for pediatric studies of drugs
- 42 U.S.C. § 284n — Certain demonstration projects
- 42 U.S.C. § 285a-3 — 285a–3. National cancer research and demonstration centers
- 42 U.S.C. § 285a-9 — 285a–9. Grants for education, prevention, and early detection of radiogenic cancers and diseases
- 42 U.S.C. § 285a-10 — 285a–10. Research, information, and education with respect to blood cancer
- 42 U.S.C. § 285b-7a — 285b–7a. Heart attack, stroke, and other cardiovascular diseases in women
- 42 U.S.C. § 285b-7b — 285b–7b. Coordination of Federal asthma activities
- 42 U.S.C. § 285c-3 — 285c–3. Interagency coordinating committees
- 42 U.S.C. § 285c-9 — 285c–9. Juvenile diabetes
- 42 U.S.C. § 285d-6a — 285d–6a. Lupus
- 42 U.S.C. § 285d-7 — 285d–7. Advisory Board
- 42 U.S.C. § 285d-8 — 285d–8. Juvenile arthritis and related conditions
- 42 U.S.C. § 285e-10 — 285e–10. Aging processes regarding women
- 42 U.S.C. § 285e-10a — 285e–10a. Alzheimer's clinical research and training awards
- 42 U.S.C. § 285f-2 — 285f–2. Research and research training regarding tuberculosis
- 42 U.S.C. § 285f-3 — 285f–3. Sexually transmitted disease clinical research and training awards
- 42 U.S.C. § 285g-4 — 285g–4. National Center for Medical Rehabilitation Research
- 42 U.S.C. § 285g-5 — 285g–5. Research centers with respect to contraception and infertility
- 42 U.S.C. § 285g-9 — 285g–9. Fragile X
- 42 U.S.C. § 285g-10 — 285g–10. Investment in tomorrow's pediatric researchers
- 42 U.S.C. § 285m-4 — 285m–4. National Institute on Deafness and Other Communication Disorders Advisory Board
- 42 U.S.C. § 285m-5 — 285m–5. Interagency Coordinating Committee
- 42 U.S.C. § 285n — Purpose of Institute
- 42 U.S.C. § 285o — Purpose of Institute
- 42 U.S.C. § 285o-2 — 285o–2. Drug Abuse Research Centers
- 42 U.S.C. § 285o-4 — 285o–4. Medication Development Program
- 42 U.S.C. § 285p — Purpose of Institute
- 42 U.S.C. § 285p-2 — 285p–2. Office of Rural Mental Health Research
- 42 U.S.C. § 285r — Purpose of the Institute
- 42 U.S.C. § 285s — Purpose of Institute
- 42 U.S.C. § 286a-1 — 286a–1. Library facilities
- 42 U.S.C. § 287a-1 — 287a–1. Biennial report
- 42 U.S.C. § 287a-2 — 287a–2. Biomedical and behavioral research facilities
- 42 U.S.C. § 287a-3 — 287a–3. Construction of regional centers for research on primates
- 42 U.S.C. § 287a-4 — 287a–4. General clinical research centers
- 42 U.S.C. § 287c-11 — 287c–11. Dietary supplements
- 42 U.S.C. § 287c-31 — 287c–31. Purpose of Center
- 42 U.S.C. § 287c-32 — 287c–32. Centers of excellence for research education and training
- 42 U.S.C. § 287c-33 — 287c–33. Loan repayment program for minority health disparities research
- 42 U.S.C. § 287c-34 — 287c–34. General provisions regarding the Center
- 42 U.S.C. § 288 — Ruth L. Kirschstein National Research Service Awards
- 42 U.S.C. § 288-1 — 288–1. Loan repayment program for research with respect to acquired immune deficiency syndrome
- 42 U.S.C. § 288-5a — 288–5a. Loan repayment program regarding clinical researchers
- 42 U.S.C. § 289a — Peer review requirements
- 42 U.S.C. § 289a-1 — 289a–1. Certain provisions regarding review and approval of proposals for research
- 42 U.S.C. § 289c — Research on public health emergencies
- 42 U.S.C. § 290b — Establishment and duties of Foundation
- 42 U.S.C. § 300c-12 — 300c–12. Sudden infant death syndrome research
- 42 U.S.C. § 300u-9 — 300u–9. Education regarding DES
- 42 U.S.C. § 300cc-41 — 300cc–41. Additional authorities
- 42 U.S.C. § 300cc-43 — 300cc–43. Emergency Discretionary Fund
- 42 U.S.C. § 300cc-45 — 300cc–45. General provisions regarding Office
- 42 U.S.C. § 1397dd — Allotments
- 42 U.S.C. § 1397ee — Payments to States
- 42 U.S.C. § 242q–4 — Definitions
- 42 U.S.C. § 242q–5 — Authorization of appropriations
- 42 U.S.C. § 280e–3 — Study in certain States to determine factors contributing to elevated breast cancer mortality rates
- 42 U.S.C. § 283a–1 — Annual reporting to prevent fraud and abuse
- 42 U.S.C. § 283a–2 — Annual reporting regarding training of graduate students for doctoral degrees
- 42 U.S.C. § 283a–3 — Establishment of program regarding DES
- 42 U.S.C. § 283k — Biomedical and behavioral research facilities
- 42 U.S.C. § 283l — Construction of regional centers for research on primates
- 42 U.S.C. § 285a–3 — National cancer research and demonstration centers
- 42 U.S.C. § 285a–9 — Grants for education, prevention, and early detection of radiogenic cancers and diseases
- 42 U.S.C. § 285a–10 — Research, information, and education with respect to blood cancer
- 42 U.S.C. § 285b–7a — Heart attack, stroke, and other cardiovascular diseases in women
- 42 U.S.C. § 285b–7b — Coordination of Federal asthma activities
- 42 U.S.C. § 285c–3 — Interagency coordinating committees
- 42 U.S.C. § 285c–9 — Juvenile diabetes
- 42 U.S.C. § 285d–6a — Lupus
- 42 U.S.C. § 285d–7 — Advisory Board
- 42 U.S.C. § 285d–8 — Juvenile arthritis and related conditions
- 42 U.S.C. § 285e–10 — Aging processes regarding women
- 42 U.S.C. § 285e–10a — Alzheimer’s clinical research and training awards
- 42 U.S.C. § 285f–2 — Research and research training regarding tuberculosis
- 42 U.S.C. § 285f–3 — Sexually transmitted disease clinical research and training awards
- 42 U.S.C. § 285g–4 — National Center for Medical Rehabilitation Research
- 42 U.S.C. § 285g–5 — Research centers with respect to contraception and infertility
- 42 U.S.C. § 285g–9 — Fragile X
- 42 U.S.C. § 285g–10 — Investment in tomorrow’s pediatric researchers
- 42 U.S.C. § 285m–4 — National Institute on Deafness and Other Communication Disorders Advisory Board
- 42 U.S.C. § 285m–5 — Interagency Coordinating Committee
- 42 U.S.C. § 285o–2 — Drug Abuse Research Centers
- 42 U.S.C. § 285o–4 — Medication Development Program
- 42 U.S.C. § 285p–2 — Office of Rural Mental Health Research
- 42 U.S.C. § 285t — Purpose of Institute
- 42 U.S.C. § 285t–1 — Centers of excellence for research education and training
- 42 U.S.C. § 285t–2 — Repealed.
- 42 U.S.C. § 285t–3 — General provisions regarding the Institute
- 42 U.S.C. § 286a–1 — Library facilities
- 42 U.S.C. § 287a–1 — Office of Rare Diseases
- 42 U.S.C. § 287a–2 — Rare disease regional centers of excellence
- 42 U.S.C. § 287a–4 — General clinical research centers
- 42 U.S.C. § 287c–11 — Dietary supplements
- 42 U.S.C. § 288–1 — Intramural loan repayment program
- 42 U.S.C. § 289a–1 — Certain provisions regarding review and approval of proposals for research
- 42 U.S.C. § 300c–12 — Sudden infant death syndrome research
- 42 U.S.C. § 300u–9 — Education regarding DES
- 42 U.S.C. § 300cc–41 — Additional authorities
- 42 U.S.C. § 300cc–43 — Emergency Discretionary Fund
- 42 U.S.C. § 300cc–45 — General provisions regarding Office